Drug Type Small molecule drug |
Synonyms RP 4010, RP4010 |
Target |
Action inhibitors |
Mechanism ORAI1 inhibitors(Calcium release-activated calcium channel protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Phase 1 | United States | 11 May 2017 | |
Lymphoma | Phase 1 | Australia | 11 May 2017 | |
Acute Myeloid Leukemia | Preclinical | Switzerland | 14 Oct 2019 | |
Gastrointestinal Neoplasms | Preclinical | United States | 27 Mar 2019 |